GOCM
BLCM

Green Owl Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Green Owl Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,000
Closed -$1.74M – 129
2015
Q3 		$1.74M Buy
12,000
+3,000
+33% +$551K 1.35% 25
2015
Q2 		$1.91M Buy
9,000
+900
+11% +$221K 1.36% 22
2015
Q1 		$1.88M Buy
+8,100
New +$1.96M 1.42% 27

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Green Owl Capital Management's BLCM Position: Q4 2015 in Review

Green Owl Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2015, closing a stake of 12,000 shares — an estimated $1.74M sold.

Green Owl Capital Management first reported a position in BLCM in Q1 2015 and held it in 3 quarters. The position peaked at $1.91M in Q2 2015. 81 funds tracked by Wall St. Rank hold BLCM as of Q4 2015.

  • Green Owl Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Green Owl Capital Management sold 12,000 Bellicum Pharmaceuticals, Inc. shares in Q4 2015, an estimated $1.74M.
  • Green Owl Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Green Owl Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $1.91M in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2015.

Based on Green Owl Capital Management's 13F filing for Q4 2015, filed 28 Jan 2016.